In a filing, Mirum Pharmaceuticals Inc revealed its PRESIDENT AND COO Radovich Peter unloaded Company’s shares for reported $85545.0 on Jan 07 ’25. In the deal valued at $42.82 per share,1,998 shares were sold. As a result of this transaction, Radovich Peter now holds 27,015 shares worth roughly $1.17 million.
Then, Peetz Christopher sold 7,489 shares, generating $320,644 in total proceeds. Upon selling the shares at $42.82, the CHIEF EXECUTIVE OFFICER now owns 119,359 shares.
Before that, Howe Jolanda sold 750 shares. Mirum Pharmaceuticals Inc shares valued at $32,111 were divested by the SVP, GLOBAL CONTROLLER at a price of $42.82 per share. As a result of the transaction, Howe Jolanda now holds 2,926 shares, worth roughly $0.13 million.
Stifel initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on April 17, 2024; the price target was $48. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley started covering the stock on November 13, 2023. It rated MIRM as “an Overweight”.
Price Performance Review of MIRM
On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock fall -1.55% to $43.32. Over the last five days, the stock has gained 0.53%. Mirum Pharmaceuticals Inc shares have risen nearly 4.76% since the year began. Nevertheless, the stocks have risen 61.16% over the past one year. While a 52-week high of $48.89 was reached on 01/14/25, a 52-week low of $23.14 was recorded on 01/10/25. SMA at 50 days reached $42.83, while 200 days put it at $36.19.
Levels Of Support And Resistance For MIRM Stock
The 24-hour chart illustrates a support level at 42.64, which if violated will result in even more drops to 41.95. On the upside, there is a resistance level at 44.57. A further resistance level may holdings at 45.81. The Relative Strength Index (RSI) on the 14-day chart is 54.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.69, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 39.52%. Stochastics %K at 63.39% indicates the stock is a holding.
How much short interest is there in Mirum Pharmaceuticals Inc?
A steep rise in short interest was recorded in Mirum Pharmaceuticals Inc stocks on 2024-12-31, dropping by -0.29 million shares to a total of 6.43 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 6.72 million shares. There was a decline of -4.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.
